Wednesday, August 17, 2016

Industry Trends: Clinical Trials & Development

Steven Whittaker, Executive Director, Avoca Quality Consortium and Senior Consultant, The Avoca Group joins the speaking faculty at the upcoming Partnerships in Clinical Trials US conference. The state of the industry is constantly evolving, and Steven sat down with the PCT US team to say a few words on the current industry trends, his biggest concerns, and what he feels the secret to long-term success is, prior to his talk this October in Boston.

What are the current trends in the clinical trials industry today?

SW: The industry is continuing to trend toward more complex clinical development programs and trials that are researching more difficult to treat illnesses. This trend includes a continued expansion of the use of CROs and other technical service providers; including the use of innovative solutions such as devices, mobile technology, enhancements in patient consent processes/tools, use of big data, and pre-competitive collaborations to address quality and capabilities development. The challenges focus on addressing these changes through efficient, cost-effective methodologies that ensure compliance, quality and timeliness without undue burden of complex oversight processes and resources from sponsor organizations.

What are your top three biggest concerns about the industry?

SW: 1) Costs and inefficiencies are unsustainable. 2) Leaders struggle with incorporating potentially beneficial technology and innovation without inserting cumbersome compliance processes within a highly regulated industry. 3) Potential patients, and society in general, is fairly disengaged from clinical trials as a treatment option, affecting perceptions of clinical research and significantly hampering the ability to recruit and retain subjects within clinical trials.

What is the secret to long-term success in your opinion?

SW: Leadership that is able to align clinical development teams and organizations across sponsors, providers, regulators, investigative sites and patients. Few success stories to date, but some pre-competitive industry consortia (e.g. TransCelerate, Avoca Quality Consortium, CTTI) are beginning to demonstrate success.

Join Steven and many other industry experts this October in Boston, MA for Partnerships in Clinical Trials US. Click here to learn more.

No comments: